Guideline Background and Scope

Apuntes

AMERICAN THORACIC SOCIETY DOCUMENTS Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline Jussi J. Saukkonen*, Raquel Duarte*, Sonal S. Munsiff*, Carla A. Winston*, Manoj J. Mammen, Ibrahim Abubakar, Carlos Acu~na-Villaordu~na, Pennan M. Barry, Mayara L. Bastos, Wendy Carr, Hassan Chami, Lisa L. Chen, Terence Chorba, Charles L. Daley, Anthony J. Garcia-Prats, Kelly Holland, Ioannis Konstantinidis, Marc Lipman, Giovanni Battista Migliori, Farah M. Parvez, Adrienne E. Shapiro, Giovanni Sotgiu, Jeffrey R. Starke, Angela M. Starks, Sanket Thakore, Shu-Hua Wang, Jonathan M. Wortham, and Payam Nahid; on behalf of the American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America THIS OFFICIAL CLINICAL PRACTICE GUIDELINE WAS APPROVED BY THE AMERICAN T HORACIC SOCIETY (ATS) AND THE I NFECTIOUS D ISEASES SOCIETY OF AMERICA (IDSA) SEPTEMBER 2024, WAS CLEARED BY THE U.S. CENTERS FOR D ISEASE CONTROL AND P REVENTION (CDC) SEPTEMBER 2024, AND WAS APPROVED BY THE EUROPEAN RESPIRATORY SOCIETY (ERS) OCTOBER 2024 Abstract Background: O...